These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22021170)

  • 41. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
    Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
    Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker.
    Kloos R; van der Sluis IM; Mastrobattista E; Hennink W; Pieters R; Verhoef JJ
    Br J Haematol; 2020 May; 189(3):442-451. PubMed ID: 31883112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Allergic reactions in treatment with L-asparaginase. Significance of specific IgE antibodies].
    Körholz D; Wahn U; Jürgens H; Wahn V
    Monatsschr Kinderheilkd; 1990 Jan; 138(1):23-5. PubMed ID: 2314401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
    Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
    Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trial.
    Escherich G; Zur Stadt U; Zimmermann M; Horstmann MA;
    Br J Haematol; 2013 Oct; 163(2):240-7. PubMed ID: 23937310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia.
    Battistel AP; Rocha BSD; Santos MTD; Daudt LE; Michalowski MB
    Hematol Transfus Cell Ther; 2021; 43(1):9-14. PubMed ID: 32014473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
    Park YK; Abuchowski A; Davis S; Davis F
    Anticancer Res; 1981; 1(6):373-6. PubMed ID: 7046623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults.
    Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
    AJR Am J Roentgenol; 2007 Dec; 189(6):1533-8. PubMed ID: 18029897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia.
    Yang L; Panetta JC; Cai X; Yang W; Pei D; Cheng C; Kornegay N; Pui CH; Relling MV
    J Clin Oncol; 2008 Apr; 26(12):1932-9. PubMed ID: 18421047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The allergic reaction to intravenous induction agents.
    Watkins J
    Br J Hosp Med; 1986 Jul; 36(1):45-8. PubMed ID: 3779187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.
    Taylor CW; Dorr RT; Fanta P; Hersh EM; Salmon SE
    Cancer Chemother Pharmacol; 2001; 47(1):83-8. PubMed ID: 11221967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma.
    Agrawal NR; Bukowski RM; Rybicki LA; Kurtzberg J; Cohen LJ; Hussein MA
    Cancer; 2003 Jul; 98(1):94-9. PubMed ID: 12833461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia.
    Douer D; Aldoss I; Lunning MA; Burke PW; Ramezani L; Mark L; Vrona J; Park JH; Tallman MS; Avramis VI; Pullarkat V; Mohrbacher AM
    J Clin Oncol; 2014 Mar; 32(9):905-11. PubMed ID: 24516026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pegaspargase (Oncaspar).
    Ettinger AR
    J Pediatr Oncol Nurs; 1995 Jan; 12(1):46-8. PubMed ID: 7893462
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical experiences with polyethylene glycol-bound E. coli L-asparaginase in patients with multiple recurrences of acute lymphoblastic leukemia].
    Jürgens H; Schwamborn D; Körholz D; Wahn V; Göbel U
    Klin Padiatr; 1988; 200(3):184-9. PubMed ID: 3210651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia.
    Nesbit M; Chard R; Evans A; Karon M; Hammond GD
    Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asparaginase Erwinia chrysanthemi (Erwinaze®): a guide to its use in acute lymphoblastic leukemia in the USA.
    Keating GM
    BioDrugs; 2013 Aug; 27(4):413-8. PubMed ID: 23794007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peg-asparaginase for acute lymphoblastic leukemia.
    Rytting M
    Expert Opin Biol Ther; 2010 May; 10(5):833-9. PubMed ID: 20345338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia.
    Pound CM; Keene DL; Udjus K; Humphreys P; Johnston DL
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):183-6. PubMed ID: 17356399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.
    Ponvert C; Perrin Y; Bados-Albiero A; Le Bourgeois M; Karila C; Delacourt C; Scheinmann P; De Blic J
    Pediatr Allergy Immunol; 2011 Jun; 22(4):411-8. PubMed ID: 21535179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.